Obermatt
See Similar Stocks →

Sotera Health

NSQ:SHC · US83601L1026
Life Sciences Tools & ServicesLarge

360

59
EV / EBIT92
Price / Owner Earnings16
Owner Earnings Yield51
Dividend Yield1
Price/Sales74
EV / Gross Profit48
Price/Book29
Return on Capital83
Cash Return on Capital55
Return on Equity92
EBIT Margin95
Gross Profitability57
Cash Conversion62
Accruals44
Owner Earnings Margin57
Sales growth55
Profit Growth84
Long-Term EPS Growth10
Owner Earnings Growth94
Reinvestment62
Price momentum47
Debt load10
Refinancing83
Debt Payback7
Liquidity73
Analyst ratings27
Opinion Changes50
Price Target Upside61
Market mood29
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Sotera Health generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
TypePublic Company
ExchangeNASDAQGS
Founded2015
Employees148
Websitesoterahealth.com
ISINUS83601L1026
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)Sound Pay Practices (USA)S&P MIDCAP (USA)
Themes
Pollution ControlDisposal and RecyclingEnvironmental ConsultingEnvironmental EngineeringHealth DiagnosticsEnvironment, Health and Safety (EH&S)OncologyHealth CareMedicalMedical Device

Description

Sotera Health Company provides end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry. The company provides end-to-end sterilization, as well as microbiological and analytical lab testing and advisory serv…

Analysis

Middle-of-the-road

Sotera Health Company is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 56.4× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone.

The trajectory is moderate and the balance sheet is stretched. The company scores 14/20 on our value-creation score: strong value creator.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
30
2023202420252026

All-time high

30

Jun 2026

All-time low

1

Jan 2025

Average rank

14

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
74
43
34
46
Price/Earnings
13
72
79
70
Price/Book
29
19
13
14
Dividend Yield
1
1
1
1
Value (overall)
7
31
28
29

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sotera Health with its peers
Gevo
NAQ:GEVO
17
CountryUSA
IndustryOil, Gas & Consumable Fuels
SizeSmall
Full Stock Analysis →
Recursion Pharmaceuticals
NSQ:RXRX
20
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Mistras
NYQ:MG
33
CountryUSA
IndustryProfessional Services
SizeMedium
Full Stock Analysis →
Kodiak Sciences
NMQ:KOD
82
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Inotiv
NAQ:NOTV
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Xbiotech
NSQ:XBIT
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →